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ABSTRACT 
    The human papillomavirus L1 major capsid protein (HPV L1), the basis of the current vaccines, self-
assembles into virus-like particles (VLPs). Herein, we describe the expression and purification of 
recombinant HPV16 L1 in E. coli system. The L1 protein was generated in a fused form using an inducible 
expression system. The recombinant GST-L1 fusion protein migrated as a 82 kDa protein in SDS-PAGE. 
The L1 proteins formed inclusion bodies which were purified by Zn
+2
 reverse staining of sodium dodecyl 
sulfate polyacrylamide gels (SDS-PAGE) as a sensitive detection method. In western blotting, the existence 
of a 82 kDa band for GST-L1 protein was confirmed by anti-HPV16 L1 monoclonal antibody Camvir 1. The 
purified protein fraction was concentrated by ultrafiltration and dialyzed against PBS. This study has 
implications for the development of L1 protein purification as well as chromatographic separation used by 
other studies. Indeed, we could present a simple method to purify L1 protein in E. coli.  
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INTRODUCTION   
The high-risk human papillomaviruses (HPVs) are 
encountered in more than 99% of cervical tumors 
and HPV16 is found in approximately 50% of the 
cases [1, 2]. The HPV capsid is composed of two 
structural proteins, L1 and L2. The major capsid 
protein, L1, which has a relative molecular weight 
of 55 kDa by reducing SDS-PAGE, is intrinsically 
able to self-assemble into virus-like particles [3, 4]. 
A number of studies have reported successful 
expression of HPV L1 proteins in bacterial 
systems, e.g., Salmonella typhimurium [5], 
Escherichia coli [6-8], Shigella flexneri [9], 
Lactobacillus casei [10] and Lactococcus lactis 
[11]. In these systems, the L1 proteins were further 
purified by chromatographic methods. In this 
report, we describe the expression of HPV16 L1 in 
the form of insoluble aggregations (Inclusion 
bodies: IBs) in BL21 E. coli. Then, the permanent 
Zn
+2
 reverse staining method was used for the 
detection and purification of L1 fusion protein in 
polyacrylamide gel. This method is a “negative 
staining” with translucent proteins and an unclear 
gel background. The reverse staining using 
imidazole and zinc salts for protein detection in 
electrophoresis gels was originally introduced in 
1990 [12, 13]. The method is based on the selective 
precipitation of a white imidazole-zinc complex all 
along the gel except in the protein bands [14]. 
Imidazole-zinc reverse stain is known for its high 
sensitivity, ease of use and cost-effective feature. It 
was later adapted to allow high-sensitivity negative 
detection of nucleic acids and bacterial 
lipopolysaccharides [12]. In addition, the 
sequencing of protein bands only detected by 
reverse staining on the gel but not by Coomassie 
blue staining [15].  
 
MATERIALS AND METHODS 
Expression of HPV16 L1 protein   
     The HPV16 L1 gene (accession no. 
AJ313179.1, kindly provided by Prof. Martin 
Muller, German Cancer Research Center (dkfz), 
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Germany) was cloned into the SmaI/NotI sites of 
pGEX vector [Invitrogen, received as a gift from 
Prof. Martin Muller]. The pGEX vector enables the 
expression of a fusion protein with a GST-tag at N-
terminus. The E. coli BL21 strain was transformed 
with pGEX-L1 and grown at 37˚C in LB broth 
supplemented with ampicillin and 
chloramphenicol. For the production of 
recombinant GST-L1 (rGST-L1), the cultures were 
grown to an optical density of 0.8-1 at 600 nm. L1 
expression was then induced by the addition of 
isopropyl-b-D-thiogalactopyranoside (IPTG) to a 
concentration of 1 mM. After a 2 h induction 
period, the cells were harvested by centrifugation 
at 8000 rpm for 10 min at 4°C. Protein samples 
were analyzed by SDS-PAGE in 12.5% (W/V) 
polyacrylamide gel followed by staining with 
coomassie brilliant blue. 
Purification and immunoblot detection of L1 
protein from inclusion bodies 
A 500 ml induced culture of pGEX-L1 transformed 
E.coli BL21 was harvested by centrifugation as 
above described and the cells were washed with 
phosphate-buffered saline (PBS), pelleted by 
centrifugation and stored at -20°C until required. 
Once thawed, the cell pellet was re-suspended in 
lysis buffer containing 1 M Tris-Cl (pH= 8.0), 0.5 
M EDTA and 5 M NaCl and incubated for 16 h at -
20˚C. The insoluble material was collected by 
centrifugation at 10000 rpm for 15 min at 4°C. The 
insoluble pellet was then washed about four times. 
The inclusion body (IB) which is predominantly 
L1 protein was pelleted by centrifugation at 10000 
rpm for 10 min at 4°C. The solubilisation process 
of isolated IBs was carried out at room temperature 
for 1 h with gentle agitation. An imidazole-SDS-Zn 
reverse staining method was used for further 
purification as described by Richard J. Simpson 
[13]. Fig. 1 shows the schematic model of reverse 
staining.  Proteins in each collected fraction were 
analyzed by reducing SDS–PAGE and Coomassie 
blue staining. For further confirmation, cell lysates 
were electroblotted onto protran nitrocellulose 
transfer membrane (Schleicher and Schuell 
Bioscience, Dassel, Germany) and the L1 protein 
was immunodetected using the anti-HPV16 L1 
monoclonal antibody Camvir 1 (Prof. Martin 
Muller, German Cancer Research Center (dkfz), 
Germany) in combination with the secondary 
antibody, peroxidase conjugated rabbit anti-mouse 
IgG (Sigma). The reaction signals were detected 
using peroxidase substrate 3, 3’-Diaminobenzidine 
(DAB, Sigma). Then, the purified protein fraction 
was concentrated by ultrafiltration and dialyzed 
against PBS. Protein concentration was measured 
using BCA assay kit (Pierce, Rockford, USA). The 
recombinant protein was kept at -70˚ C until use.  
 
RESULTS 
HPV16 L1 expression in E. coli 
     The induction of HPV16 L1 expression in 
IPTG-treated cultures of pGEX-L1-transformed E. 
coli BL21 was analyzed by reducing SDS–PAGE. 
As shown in Fig. 2, a protein of approximately 82 
kDa mass accumulated in cell lysates of IPTG-
treated cultures. This protein was not detected in 
un-induced cultures and pGEX vector as a negative 
control. Indeed, rGST-L1 and rGST migrated as a 




Figure1. Schematic model of reverse staining method 
 
Purification of the insoluble L1 protein  
The accumulation of prokaryotically expressed L1 
in IBs facilitated its purification by the series of 
centrifugation and wash steps outlined under 
Materials and Methods. This resulted in a 
preparation that was observed by reducing SDS–
PAGE as being partially pure (Fig. 3, lane 3). 
Reverse staining using Imidazole-ZnSO4 resulted 
in further purification of L1. L1 was eluted with 
ammonium carbonate/SDS (Fig. 3, lane 4). The 
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identity of the purified protein as GST-L1 was 
confirmed by western blotting using the anti-L1 
monoclonal antibody Camvir 1. The antibody 
reacted strongly to the 82 kDa protein, as well as to 
some lower molecular weight proteins which may 
result from the degradation of the full-length L1. 
Cell lysates from un-induced cultures were not 
recognized by this antibody.  
 
Figure 2. Analysis of the HPV16 L1 expression in E. coli 
BL21 cells from the recombinant expression vector pGEX-L1 
by SDS–PAGE. The samples are the lysates of un-induced 
(lane 3) and induced (lane 4) cells. The pGEX vector was used 
as a negative control (lane 1: un-induced & lane 2: induced 
cells). The rGST-L1 and rGST migrated as a 82 kDa and 27 
kDa protein in SDS-PAGE, respectively. Lane M: molecular 
weight markers.  
 
Figure 3. SDS–PAGE analysis of the protein contents in 
supernatant fractions obtained during the isolation of IBs from 
induced cultures of pGEX-L1-transformed E. coli BL21 (lane 
3). The total cell extracts from un-induced cells or IPTG-
induced cells were shown in lane 1 and 2, respectively. The 
purified HPV16 L1 in the fractions collected after reverse 




    The development of an efficient prophylactic 
vaccine against high-risk HPV types, especially 
HPV16, could greatly reduce the incidence rates of 
the disease associated with this virus. Clinical 
studies have demonstrated that either quadrivalent 
or bivalent vaccines composed of  L1 VLPs have 
high efficacy against HPV infections. Recently, 
alternatives are sought for producing an effective 
and low-cost vaccine [16]. Several approaches for 
expressing the recombinant L1 from HPV16 have 
been tested using bacteria e.g., E. coli. Bacterial 
expression systems have proven to be limited in 
producing significant quantities of recombinant 
HPV 16 L1 due to inefficient purification and the 
risk of contamination with endotoxins. Herein, we 
showed a rapid protein elution from 
polyacrylamide gel bands at room temperature by 
reverse staining after preparation of HPV16 L1 in 
the form of insoluble inclusion bodies (IBs). An 
alternative procedure for preparing inclusion 
bodies was applied using salt reagents. IBs were 
isolated by centrifugation, washed with buffer and 
finally solubilized for further purification by 
reverse staining. Detection is accomplished by gel 
incubation in an imidazole solution, followed by 
incubation in a zinc salt solution to develop a 
negative stain pattern. The protocol described here 
gives a relatively straightforward purification 
strategy. The zinc/imidazole staining procedure for 
visualizing proteins in acrylamide gels is based on 
differential salt binding. The sensitivity of the 
method has been markedly improved by altering 
the composition of the precipitated salt to a 
complex of zinc and imidazole [17, 18]. Zinc-
mediated protein fixation in the gel is fully 
reversible and the eluted biomolecules are neither 
chemically modified nor contaminated with 
organic dyes. This method can detect the bands 
corresponding to 5 ng of protein [14]. In the 
presence of SDS and 2-mercaptoethanol, the rGST-
L1 migrated as a 82 kDa protein during poly 
acrylamide gel electrophoresis. The method used to 
purify L1 fusion protein has been scaled up for 
large scale production of this protein to obtain the 
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     The present study indicated the efficient 
production of L1 fusion protein in an E.coli system 
using IB isolation followed by reverse staining 
with Imidazole/Zinc. 
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